Category:
Prophylactic Biological Products
CAS NO:
1825352-65-5
Standard:
EP,
Risdiplam
| Status | Pipeline |
| Development phase | Initial stage |
| Therapeutic cat. | Musculo-skeletal |
| CAS No. | 1825352-65-5 |
| OEB No. |
4 |
Drug description
Risdiplam is an oral mRNA splicing modifier used in the treatment of spinal muscular atrophy (SMA).
Disclaimer: Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement.